ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 132 filers reported holding ANTARES PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,147,000 | +47.2% | 378,685 | +32.3% | 0.00% | 0.0% |
| Q4 2018 | $779,000 | -59.5% | 286,248 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,924,000 | +158.3% | 572,496 | +98.2% | 0.00% | 0.0% |
| Q2 2018 | $745,000 | +31.6% | 288,777 | +12.3% | 0.00% | 0.0% |
| Q1 2018 | $566,000 | +10.5% | 257,124 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $512,000 | -38.5% | 257,124 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $833,000 | +0.6% | 257,124 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $828,000 | +326.8% | 257,124 | +15.0% | 0.00% | – |
| Q1 2016 | $194,000 | -28.1% | 223,533 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $270,000 | -28.9% | 223,533 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $380,000 | -18.3% | 223,533 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $465,000 | +3.8% | 223,533 | +35.1% | 0.00% | 0.0% |
| Q1 2015 | $448,000 | +5.4% | 165,434 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $425,000 | +40.3% | 165,434 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $303,000 | -31.4% | 165,434 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $442,000 | -22.2% | 165,434 | +2.0% | 0.00% | 0.0% |
| Q1 2014 | $568,000 | -21.9% | 162,222 | 0.0% | 0.00% | -50.0% |
| Q4 2013 | $727,000 | – | 162,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|